Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 33, 2007 - Issue 6
Submit an article Journal homepage
193
Views
22
CrossRef citations to date
0
Altmetric
Original

Case Series on the Safe Use of Buprenorphine/Naloxone in Individuals with Acute Hepatitis C Infection and Abnormal Hepatic Liver Transaminases

Robert D. Bruce Yale University AIDS Program, New Haven, Connecticut, USACorrespondence[email protected]
, M.D., M.A. &
Frederick L. Altice Yale University AIDS Program, New Haven, Connecticut, USA
, M.D.
Pages 869-874 | Published online: 07 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Michael Soyka. (2015) New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone. Substance Abuse and Rehabilitation 6, pages 1-14.
Read now
Arzu Ciftci Demirci, Hatice Gunes, Hilal Adaletli, Esra Bulanik & Ayten Erdogan. (2015) Liver enzyme levels in adolescent patients treated with buprenorphine and additional psychotropic agents. The American Journal of Drug and Alcohol Abuse 41:1, pages 107-113.
Read now
Xiaofan Li, Daryl Shorter & Thomas R Kosten. (2014) Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opinion on Pharmacotherapy 15:15, pages 2263-2275.
Read now
DonaldR. Wesson & DavidE. Smith. (2010) Buprenorphine in the Treatment of Opiate Dependence. Journal of Psychoactive Drugs 42:2, pages 161-175.
Read now

Articles from other publishers (18)

James Tidder, Alexander M. Baldacchino & Joseph Tay Wee Teck. 2022. Opioids. Opioids 315 342 .
Devin A. Oller, Chase Thornton, Paul A. Nuzzo & Laura C. Fanucchi. (2021) Buprenorphine Induction in Persons With Opioid Use Disorder Hospitalized with Acute Hepatitis A. Journal of Addiction Medicine 15:3, pages 187-190.
Crossref
E. Aldemir, H. Coskunol, M. Kilic & I. Sert. (2016) Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases. Transplantation Proceedings 48:8, pages 2769-2772.
Crossref
Jeanette M. Tetrault, Janet P. Tate, E. Jennifer Edelman, Adam J. Gordon, Vincent Lo ReIIIIII, Joseph K. Lim, David Rimland, Joseph Goulet, Stephen Crystal, Julie R. Gaither, Cynthia L. Gibert, Maria C. Rodriguez-Barradas, Lynn E. Fiellin, Kendall Bryant, Amy C. Justice & David A. Fiellin. (2016) Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal of Substance Abuse Treatment 68, pages 62-67.
Crossref
Hassan Soleimanpour, Saeid Safari, Kavous Shahsavari Nia, Sarvin Sanaie & Seyed Moayed Alavian. (2016) Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepatitis Monthly 16:4.
Crossref
Michael Soyka. (2015) Alcohol Use Disorders in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Treatment. European Addiction Research 21:2, pages 78-87.
Crossref
Michael Soyka, Markus Backmund, Peggy Schmidt & Sabine Apelt. (2014) Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study. The American Journal on Addictions 23:6, pages 563-569.
Crossref
M. Bosilkovska, Y. Daali, B. Walder & J. Desmeules. (2013) Utilisation des analgésiques dans l’insuffisance hépatiqueUse of analgesics in patients with hepatic impairment. Douleur et Analgésie 26:4, pages 209-217.
Crossref
Ryan Schwarz, Alexei Zelenev, R. Douglas Bruce & Frederick L. Altice. (2012) Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. Journal of Substance Abuse Treatment 43:4, pages 451-457.
Crossref
Marija Bosilkovska, Bernhard Walder, Marie Besson, Youssef Daali & Jules Desmeules. (2012) Analgesics in Patients with Hepatic Impairment. Drugs 72:12, pages 1645-1669.
Crossref
Gregory M. Lucas, Geetha Beauchamp, Apinun Aramrattana, Yiming Shao, Wei Liu, Liping Fu, J. Brooks Jackson, David D. Celentano, Paul Richardson & David Metzger. (2012) Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. International Journal of Drug Policy 23:2, pages 162-165.
Crossref
Jeanette M. Tetrault & David A. Fiellin. (2012) Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals. Drugs 72:2, pages 217-228.
Crossref
Pamela Vergara-Rodriguez, Mary Jo Tozzi, Michael Botsko, Vijay Nandi, Frederick Altice, James E Egan, Patrick G O'Connor, Lynn E Sullivan & David A Fiellin. (2011) Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:Supplement 1, pages S62-S67.
Crossref
DONALD P. LEVINE & PATRICIA D. BROWN. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 3875 3890 .
Laurent Michel, Jean-Philippe Lang & Pascal Melin. 2009. Psychiatrie, VIH et hépatite C. Psychiatrie, VIH et hépatite C 142 150 .
Richard J. Bodnar. (2008) Endogenous opiates and behavior: 2007. Peptides 29:12, pages 2292-2375.
Crossref
N. K. GUPTA & J. H. LEWIS. (2008) Review article: the use of potentially hepatotoxic drugs in patients with liver disease. Alimentary Pharmacology & Therapeutics 28:9, pages 1021-1041.
Crossref
Thomas F. KresinaDiana SylvestreLeonard SeeffAlain H. LitwinKenneth HoffmanRobert LubranH. Westley Clark. (2008) Hepatitis Infection in the Treatment of Opioid Dependence and Abuse. Substance Abuse: Research and Treatment 1, pages SART.S580.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.